芬罗唑 T27320

Product Introduction
Bioactivity


英文名: Finrozole

描述: Finrozole (MPV 2213ad) 是一种新型选择性芳香化酶抑制剂，对于乳房发育是部分可逆的。

体内活性: To investigate the pharmacokinetics of finrozole (MPV-2213ad), a novel competitive aromatase enzyme inhibitor, in healthy male volunteers. METHODS: The study was an open, partly randomized cross-over study including 23 volunteers receiving single doses of 3, 9 mg, or 30 mg of finrozole as tablets or solution with 14 days between the administrations. The highest dose was given as tablets only. Serum concentrations of finrozole were determined using high performance liquid chromatography combined with mass spectrometry. RESULTS: The mean time to peak serum concentration ranged from 2.5 to 3.1, and 0.6-0.7 h after tablets and solution, respectively. The Cmax values increased as the dose increased. The calculated apparent mean elimination half-life (t(1/2,z)) was approximately 3 h after the solution, and approximately 8 h after the tablet. The AUC(0, infinity) after finrozole tablets increased proportionally from 3 mg to 9 mg and from 3 to 30 mg. The calculated relative mean bioavailabilities (AUC(0, infinity)-ratio) for the 3 mg and 9 mg doses of finrozole as tablets were 89% and 78%, respectively. CONCLUSIONS: The absorption of finrozole from the tablet formulation was relatively rapid, and the apparent elimination half-life was longer after the tablet than after the solution, probably reflecting the overlap of the absorption with the elimination phase.[1]

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 50 mg/mL (155.12 mM)


关键字: MPV2213 | Finrozole

相关产品: Org30958 | Endoxifen | Flavanone | YM 511 | Aminoglutethimide | alpha-Naphthoflavone | Anastrozole | (-)-Vorozole | Calceolarioside B | Fadrozole hydrochloride

相关库: Bioactive Compounds Library Max | Inhibitor Library | Bioactive Compound Library

芬罗唑 T27320信息由TargetMol中国为您提供，如您想了解更多关于芬罗唑 T27320报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途